Skip to main content
TipRanks
Go Ultimate75% OFF

Glow LifeTech (9DO) AI Stock Analysis

0 Followers
DE:9DO

Glow LifeTech

(Frankfurt:9DO)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue GrowthTTM revenue of about 2.31M, up from 2.05M in 2025 and 0.84M in 2024, indicates that commercialization is gaining traction. Continued expansion would provide a larger base over which operating costs can be absorbed and could support improving economics over the next several quarters.
Negative Factors
Negative MarginsTTM net margin of about -13% and operating margin of about -17% show that the business still loses money at both the overall and operating levels. Until revenue growth translates into positive margins, profitability remains dependent on continued cost control and further scale.

Glow LifeTech (9DO) vs. iShares MSCI Germany ETF (EWG)

-50%-25%0%25%50%75%DE:9DO-36.00%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 6.74M
Dividend Yield
―
Average Volume (3M)
9,166
Price to Earnings (P/E)
-43.8
Beta (1Y)
0.20
Revenue Growth
47.67%
EPS Growth
91.80%
Country
Germany
Employees
5
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Glow LifeTech Business Overview & Revenue Model

Company Description

Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced tec...

Glow LifeTech Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:9DO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:MDMATSE:MDMA50NeutralCAD 16.39M-9.73-72.15%―224.46%28.37%
TSE:PREVTSE:PREV44NeutralCAD 12.76M-16.6710.15%――-36.36%
TSE:KNETSE:KNE40UnderperformCAD 6.15M-2.05273.53%―――
TSE:CSCITSE:CSCI34UnderperformCAD 8.49M-0.46-48.52%―-13.00%75.31%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%150%DE:9DOTSE:CSCITSE:KNETSE:QPTTSE:PREVTSE:MDMADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:9DO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:9DOGlow Lifetech Corp0.02-0.01-36.00%
TSE:CSCICosciens Biopharma Inc.8.66-1.24-12.53%
TSE:KNEKane Biotech0.03-0.01-25.00%
TSE:QPTQuest Pharmatech0.02-0.02-50.00%
TSE:PREVPreveCeutical Medical 0.020.000.00%
TSE:MDMAPharmAla Biotech Holdings, Inc.0.150.0325.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.